Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma von Ramakrishnan, Vijay G, Miller, Kevin C, Macon, Elaine P, Kimlinger, Teresa K, Haug, Jessica, Kumar, Sanjay, Gonsalves, Wilson I, Rajkumar, S Vincent, Kumar, Shaji K

Volltext

Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial von GALANIS, Evanthia, KEITH ANDERSON, S, KAUFMANN, Timothy J, BUCKNER, Jan C, LAFKY, Jackie M, UHM, Joon H, GIANNINI, Caterina, KUMAR, Shaji K, KIMLINGER, Teresa K, NORTHFELT, Donald W, FLYNN, Patrick J, JAECKLE, Kurt A

Volltext

Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression von Kumar, Shaji, Witzig, Thomas E., Timm, Michael, Haug, Jessica, Wellik, Linda, Kimlinger, Teresa K., Greipp, Philip R., Rajkumar, S. Vincent

Volltext

Sorafenib, a multikinase inhibitor, is effective in vitro against non-hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin von Ramakrishnan, Vijay, Timm, Michael, Haug, Jessica L., Kimlinger, Teresa K., Halling, Timothy, Wellik, Linda E., Witzig, Thomas E., Vincent Rajkumar, S., Adjei, Alex A., Kumar, Shaji

Volltext

R-(-)−gossypol (AT-101) activates programmed cell death in multiple myeloma cells von Kline, Michael P, Rajkumar, S. Vincent, Timm, Michael M, Kimlinger, Teresa K, Haug, Jessica L, Lust, John A, Greipp, Philip R, Kumar, Shaji

Volltext

Fish is superior to PCR in detecting t(14;18)(q32;q21)-IgH/bcl-2 in follicular lymphoma using paraffin-embedded tissue samples von EINERSON, Richard R, KURTIN, Paul J, DAYHARSH, Gerald A, KIMLINGER, Teresa K, REMSTEIN, Ellen D

Volltext

Expression of CD52 on plasma cells in plasma cell proliferative disorders von Kumar, Shaji, Kimlinger, Teresa K., Lust, John A., Donovan, Kathleen, Witzig, Thomas E.

Volltext

Immunological Consequences of Lenalidomide with and without Dexamethasone in Newly Diagnosed Multiple Myeloma von Kloeber, Jake A., Kimlinger, Teresa K., Haug, Jessica L., Henderson, Kimberly J., Rajkumar, S.Vincent, Kumar, Shaji K.

Volltext

Gene Expression Profiling of Structural and Functional High-Risk Multiple Myeloma von Binder, Moritz, Rajkumar, S. Vincent, Lacy, Martha Q., Haug, Jessica L., Dispenzieri, Angela, Henderson, Kimberly J., Kimlinger, Teresa K., Stewart, A. Keith, Bergsagel, P. Leif, Kumar, Shaji K.

Volltext

The Transcriptome of Immunomodulator-Resistant Multiple Myeloma von Binder, Moritz, Rajkumar, S. Vincent, Lacy, Martha Q., Haug, Jessica L., Dispenzieri, Angela, Henderson, Kimberly J., Kimlinger, Teresa K., Kumar, Shaji K.

Volltext

Flt-3 and c-kit mutation studies in a spectrum of chronic myeloid disorders including systemic mast cell disease von Pardanani, Animesh, Reeder, Terra L., Kimlinger, Teresa K., Baek, Jin Y., Li, Chin-Y., Butterfield, Joseph H., Tefferi, Ayalew

Volltext

Differential expression of CD2 on neoplastic mast cells in patients with systemic mast cell disease with and without an associated clonal haematological disorder von Pardanani, Animesh, Kimlinger, Teresa K., Reeder, Terra L., Li, Chin‐Yang, Tefferi, Ayalew

Volltext

Patterns of AKT, mTOR, ERK, and STAT3 pathway activation in MGUS, smoldering multiple myeloma, and multiple myeloma von Larsen, Jeremy Todd, Ramakrishnan, Vijay, Wellik, Linda, Kimlinger, Teresa K., Rajkumar, S. Vincent, Kumar, Shaji

Volltext

Overcoming Resistance to Apoptosis in Multiple Myeloma By Simultaneous Inhibition of Bcl2 and IAP Families of Anti-Apoptotic Proteins von Gomez, Marcus, Ramakrishnan, Vijay G., Prasad, Vivek, Kimlinger, Teresa K., Painuly, Utkarsh, Bi, Lintao, Rajkumar, Vincent, Kumar, Shaji

Volltext

Promising Pre-Clinical Activity of A-1014907, a Dual Inhibitor of Aurora Kinases and VEGFR in Multiple Myeloma von Painuly, Utkarsh, Ramakrishnan, Vijay G., Kimlinger, Teresa K., Rajkumar, S. Vincent, Kumar, Shaji K.

Volltext

Simultaneous Inhibition of cIAP1, cIAP2 and XIAP Is Required for Inducing Apoptosis in Multiple Myeloma Cells von Ramakrishnan, Vijay G., Kimlinger, Teresa K., Painuly, Utkarsh, Haug, Jessica, Rajkumar, S. Vincent, Kumar, Shaji K.

Volltext

Expression of CD123 (IL-3R-alpha), a Therapeutic Target of SL-401, on Myeloproliferative Neoplasms von Lasho, Terra, Finke, Christy, Kimlinger, Teresa K., Zblewski, Darci, Chen, Dong, Patnaik, Mrinal M., Hanson, Curtis A., Brooks, Christopher, Tefferi, Ayalew, Pardanani, Animesh

Volltext

Abstract 5669: Mechanisms of activity and drug resistance with proteasome inhibitors in multiple myeloma: Comparison of bortezomib and the investigational drug MLN9708 von Bianchi, Giada, Ramakrishnan, Vijay G., Kimlinger, Teresa K., Haug, Jessica, Rajkumar, S. Vincent, Kumar, Shaji

Volltext

Preclinical Evaluation of AT219, a Small Molecule Inhibitor of MDM2 As an Anti-Myeloma Agent von Ramakrishnan, Vijay G., Kimlinger, Teresa K., Halling, Timothy, Haug, Jessica, Painuly, Utkarsh, Rajkumar, S. Vincent, Kumar, Shaji K.

Volltext

Image Analysis and Flow Cytometric DNA Studies of Benign and Malignant Body Cavity Fluids: Reappraisal of the Role of Current Methods in the Differential Diagnosis of Reactive Vers... von Lazcano, Oscar, Chen, Li-Mien, Tsai, Cheng, Li, Chin-Yang, Katzmann, Jerry A, Sebo, Thomas J, Kimlinger, Teresa K, Baker, Julie

Volltext